Tag Archives: 5-hmC

The discovery of the “6th base”, 5-hydroxymethylated cytosine, has resulted in rapid fire publication activity.  Researchers are exploring it’s part in demethylation dynamics, and its epigenetic function. Today I wanted to highlight the paper, H. Yang, et al. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation (March 2012) Oncogene 1-7. It provides further detailed analysis that is complementary to the work described by Hafner et al., please see my Q&A with Dr. Yegnasubramanian. The Oncogene paper research group, mainly out of Fudan University, looked at additional tissue types using an anti-5-hmC antibody for immunolocalization in paraffin embedded samples. They sampled human breast, prostate, liver, lung and pancreas, comparing them with corresponding matched normal surrounding tissues. … Continue reading

Posted in Biomarkers, DNA Methylation, Diagnostics, History & Trends, Imaging, Immunohistochemistry, Oncology | Tagged , , , , | Leave a comment

They say beauty is in the eye of the beholder. For me, well done immunolocalization images demonstrate scientific artistry. Last week I was pleased to find this paper, Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers Oncotarget Sept. 2, 2011 (Haffner et al), posted on the Dr. Denise O’Keefe lab blog (E3 member). This research showed that fully differentiated adult tissues had the highest levels of 5-hmC, while stem cells had very low levels. There was uniform loss of 5hmC in cancer tissues, matched to normal adult tissues. Reductions in 5-hmC can occur independently of 5mC in solid tumors. Global loss of 5-hmC could be an early event of carcinogenesis. The work came … Continue reading

Posted in DNA Methylation, Flow Cytometry, Imaging, Immunofluorescence, Immunohistochemistry, Methyl-specific Antibodies, New Lab Methods, Oncology, Pathology, Stem Cells | Tagged , | Leave a comment